ArticleRadiology2023
Toward AI-supported US Triage of Women with Palpable Breast Lumps in a Low-Resource Setting.
Article in Radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.
- Artificial intelligence in the radiologic assessment of ductal carcinomaFrontiers in oncology · 2026Pooled it
- Diagnostic accuracy of an artificial intelligence-based breast ultrasound tool in pregnant and lactating patients.European radiology · 2026Article
- Review
- Application of Artificial Intelligence in Breast Ultrasound Diagnosis.Diagnostics (Basel, Switzerland) · 2026Review
- Training AI to Improve Distinction of Triple-Negative Invasive Breast Cancer from Cysts and Fibroadenomas on Ultrasound.Diagnostics (Basel, Switzerland) · 2026Article
- Review
- Bio-interpretable ensemble learning model for invasive pulmonary adenocarcinoma grade using CT and histopathology images.NPJ precision oncology · 2025Article
- Variational mode directed deep learning framework for breast lesion classification using ultrasound imaging.Scientific reports · 2025Article
- Progress in the Application of Artificial Intelligence in Ultrasound-Assisted Medical Diagnosis.Bioengineering (Basel, Switzerland) · 2025Review
- Clinical Application of Artificial Intelligence in Breast Ultrasound.Journal of the Korean Society of Radiology · 2025Review
- Improving breast ultrasonography education: the impact of AI-based decision support on the performance of non-specialist medical professionals.Ultrasonography (Seoul, Korea) · 2025Article
- Clinical Application of Artificial Intelligence in Ultrasound Imaging for Oncology.JMA journal · 2025Review
- Review
- Artificial Intelligence in Diagnostic Breast Ultrasound: A Comparative Analysis of Decision Support Among Radiologists With Various Levels of Expertise.European journal of breast health · 2025Article
- New Frontiers in Breast Cancer Imaging: The Rise of AI.Bioengineering (Basel, Switzerland) · 2024Review
- Artificial intelligence in breast ultrasound: application in clinical practice.Ultrasonography (Seoul, Korea) · 2024Article
- Prospective study of AI-assisted prediction of breast malignancies in physical health examinations: role of off-the-shelf AI software and comparison to radiologist performance.Frontiers in oncology · 2024Article
- Clinical Utility of Breast Ultrasound Images Synthesized by a Generative Adversarial Network.Medicina (Kaunas, Lithuania) · 2023Article
- Evolving the Era of 5D Ultrasound? A Systematic Literature Review on the Applications for Artificial Intelligence Ultrasound Imaging in Obstetrics and Gynecology.Journal of clinical medicine · 2023Review
Corrections and comments
- Commented on by
Authors and funding
10 authors at 3 institutions in 1 country.
Funding
Abstract
Background Most low- and middle-income countries lack access to organized breast cancer screening, and women with lumps may wait months for diagnostic assessment. Purpose To demonstrate that artificial intelligence (AI) software applied to breast US images obtained with low-cost portable equipment and by minimally trained observers could accurately classify palpable breast masses for triage in a low-resource setting. Materials and Methods This prospective multicenter study evaluated participants with at least one palpable mass who were enrolled in a hospital in Jalisco, Mexico, from December 2017 through May 2021. Orthogonal US images were obtained first with portable US with and without calipers of any findings at the site of lump and adjacent tissue. Then women were imaged with standard-of-care (SOC) US with Breast Imaging Reporting and Data System assessments by a radiologist. After exclusions, 758 masses in 300 women were analyzable by AI, with outputs of benign, probably benign, suspicious, and malignant. Sensitivity, specificity, and area under the receiver operating characteristic curve (AUC) were determined. Results The mean patient age ± SD was 50.0 years ± 12.5 (range, 18-92 years) and mean largest lesion diameter was 13 mm ± 8 (range, 2-54 mm). Of 758 masses, 360 (47.5%) were palpable and 56 (7.4%) malignant, including six ductal carcinoma in situ. AI correctly identified 47 or 48 of 49 women (96%-98%) with cancer with either portable US or SOC US images, with AUCs of 0.91 and 0.95, respectively. One circumscribed invasive ductal carcinoma was classified as probably benign with SOC US, ipsilateral to a spiculated invasive ductal carcinoma. Of 251 women with benign masses, 168 (67%) imaged with SOC US were classified as benign or probably benign by AI, as were 96 of 251 masses (38%,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.